```json
{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "G",
                        "position": "344"
                    },
                    "Description in input context": "E344G"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "C",
                        "position": "42"
                    },
                    "Description in input context": "R42C"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "N",
                        "alt": "S",
                        "position": "254"
                    },
                    "Description in input context": "N254S"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Q",
                        "position": "275"
                    },
                    "Description in input context": "R275Q"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "H",
                        "position": "420"
                    },
                    "Description in input context": "R420H"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "I",
                        "alt": "V",
                        "position": "2"
                    },
                    "Description in input context": "I2V"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "46"
                    },
                    "Description in input context": "A46T"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "D",
                        "alt": "N",
                        "position": "243"
                    },
                    "Description in input context": "D243N"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "H",
                        "alt": "P",
                        "position": "279"
                    },
                    "Description in input context": "H279P"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "379"
                    },
                    "Description in input context": "A379V"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "STOP",
                        "position": "395"
                    },
                    "Description in input context": "E395STOP"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "glioblastoma multiforme (GBM), colon cancer and lung cancer",
        "MONDO": "N.D."
    },
    "Experiment Method": [
        {
            "Assay Method": "Colony-forming assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "T98G, DBTRG, RKO, H441 and H358",
                "Description": "Cell lines sequenced were T98G, DBTRG, RKO, H441 and H358."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and resulted in substantially decreased colony-forming activity as compared to WT PARK2."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "All assays performed in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "pcDNA3.1, vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Student's t-test was used to performed statistical analysis"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Cell growth > 80% compared to vector control",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Cell growth < 50% compared to vector control",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Growth curve assays",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "DBTRG",
                "Description": "Transfection of WT but not mutant PARK2 into cells from the DBTRG line resulted in a reduction in the rate of cell growth"
            },
            "Readout type": "Quantitative",
             "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and expression of PARK2 with tumor-derived mutations resulted in substantially decreased colony-forming activity as compared to WT PARK2."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "All experiments were performed in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "pcDNA3.1, vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used to performed statistical analysis"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Cell growth > 80% compared to vector control",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Cell growth < 50% compared to vector control",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Mouse xenograft studies",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "DBTRG glioma cells",
                "Description": "DBTRG glioma cells stably transfected with vector alone, WT PARK2 and four PARK2 mutants were injected as xenografts"
            },
            "Readout type": "Quantitative",
             "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and WT PARK2 decreased tumor growth in vivo, a property that was reduced by the cancer-specific mutations "
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Tumor volume < 100 mm3 on day 27",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Tumor volume > 200 mm3 on day 27",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In vivo ubiquitination assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "N.D.",
                "Description": "Cancer-specific mutations in PARK2 were found to substantially compromise the association of PARK2 with ubiquitinated target proteins in cancer cells"
            },
            "Readout type": "N.D.",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and Cancer-specific mutations in PARK2 were found to substantially compromise the association of PARK2 with ubiquitinated target proteins in cancer cells"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Flow cytometry",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "N.D.",
                "Description": "Flow cytometry analysis revealed that PARK2 knockdown increased the proportion of cells in the S and the G2-M phases "
            },
            "Readout type": "N.D.",
             "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and Fluorescence-activated cell sorting analysis revealed that PARK2 knockdown increased the proportion of cells in the S and the G2-M phases"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "S phase percentage < 20%, G2/M phase percentage < 10%",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "S phase percentage > 30%, G2/M phase percentage > 20%",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunofluorescence staining",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "N.D.",
                "Description": "PARK2 knockdown cells showed a marked increase in nuclear atypia characterized by micronuclei"
            },
            "Readout type": "Qualitative",
             "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "PARK2 mutations in cancers have clear functional consequences and Immunofluorescence staining showed a significant increase in the frequency of multipolar spindles and abnormal mitoses"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PARK2 cDNA was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "vector-only control was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Normal Mitosis",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Multipolar Spindles, nuclear atypia",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```